KanryAb™ Mouse Anti-Human CD3 mAb, FITC

Localized Application Scenarios Scenario 1：Immunology Preclinical CRO Local Pain Point：Numerous FITC labeled CD3 antibodies produce high non-specific binding, which raises background and reduces resolution of T lymphocyte populations. Our Advantage：Our CD3 Positive Selection Reagent FITC Conjugated Immunophenotyping Antibody Human CD3 FITC adopts optimized conjugation technology, cutting non-specific background signal by 32% and improving the separation of target T cell populations. Scenario 2：University Flow Core Facility for Cell Sorting Local Pain Point：FITC fluorophore is prone to photobleaching and signal loss after repeated freeze-thaw cycles, causing unreliable cell sorting results. Our Advantage：Advanced fluorophore stabilization formula retains over 94% of FITC fluorescence intensity after three freeze-thaw cycles, fully compatible with our Cell Sorting Product Series. Scenario3：Biotech R&D for Immunoassay Method Development Local Pain Point：Long lead times and ba…